E-LIB Suche - Ergebnisse für: Voorhees, Peter

1

Absolute Lymphocyte Count and Outcomes of Multiple Myeloma ..:

Khouri, Jack ; Dima, Danai ; Li, Hong...
Transplantation and Cellular Therapy. , 2024

Link: https://doi.org/10.1016/..

2

Racial and ethnic differences in clinical outcomes among pa..:

Peres, Lauren C. ; Oswald, Laura B. ; Dillard, Christen M....
Blood Advances. 8 (2024) 1 - p. 251-259 , 2024

Link: https://doi.org/10.1182/..

3

PB2133: TRIAL IN PROGRESS: LINKER-MM3, A PHASE 3, OPEN-LABE..:

Weisel, Katja ; Hungria, Vania ; Quach, Hang...
HemaSphere. 7 (2023) S3 - p. e465366a , 2023

Link: https://doi.org/10.1097/..

4

P-049 Safety and efficacy of standard of care ciltacabtagen..:

Sidana, Surbhi ; Patel, Krina ; Peres, Lauren...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S61-S62 , 2023

Link: https://doi.org/10.1016/..

5

P-052 LINKER-MM3, a phase 3, open-label, randomized study o..:

Weisel, Katja ; Hungria, Vania ; Quach, Hang...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S63-S64 , 2023

Link: https://doi.org/10.1016/..

6

Factors associated with refractoriness or early progression..:

Hashmi, Hamza ; Hansen, Doris K. ; Peres, Lauren C....
Haematologica. , 2023

Link: https://doi.org/10.3324/..

7

P-002 Impact of bridging therapy (BT) on outcome of relapse..:

Afrough, Aimaz ; Hashmi, Hamza ; Hansen, Doris...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S33 , 2023

Link: https://doi.org/10.1016/..

8

Idecabtagene vicleucel chimeric antigen receptor T-cell the..:

Sidana, Surbhi ; Peres, Lauren C. ; Hashmi, Hamza...
Haematologica. 109 (2023) 3 - p. 777-786 , 2023

Link: https://doi.org/10.3324/..

9

Segmentation of tomography datasets using 3D convolutional ..:

James, Jim ; Pruyne, Nathan ; Stan, Tiberiu...
Computational Materials Science. 216 (2023) - p. 111847 , 2023

Link: https://doi.org/10.1016/..

10

PB2088: ABBV-383 IN COMBINATION WITH ANTI-CANCER REGIMENS I..:

Valdes, Cesar Rodriguez ; Weisel, Katja ; Baz, Rachid...
HemaSphere. 7 (2023) S3 - p. e60985f9 , 2023

Link: https://doi.org/10.1097/..

11

P862: A PHASE 1 FIRST-IN-HUMAN MONOTHERAPY STUDY OF ABBV-38..:

Weisel, Katja ; D'souza, Anita ; Hurd, David...
HemaSphere. 7 (2023) S3 - p. e0036307 , 2023

Link: https://doi.org/10.1097/..

12

P-226 Safety and clinical activity of belantamab mafodotin ..:

Atrash, Shebli ; Symanowski, James ; Paul, Barry...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S159-S160 , 2023

Link: https://doi.org/10.1016/..

13

P-164 Reduction in disease symptoms/impacts after daratumum..:

Silbermann, Rebecca ; Laubach, Jacob ; Kaufman, Jonathan...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S125-S126 , 2023

Link: https://doi.org/10.1016/..

14

P-277 Venetoclax versus bortezomib, in combination with dar..:

Kaufman, Jonathan ; Quach, Hang ; Baz, Rachid...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S188-S189 , 2023

Link: https://doi.org/10.1016/..

15

P-255 Efficacy of a second autologous stem cell transplant ..:

Ehsan, Hamid ; Robinson, Myra ; Atrash, Shebli...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S176 , 2023

Link: https://doi.org/10.1016/..